Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-08 15:28:00 - browse：5

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Erich Jarvis studies song birds to learn about human stuttering

leisure time

Wikipedia

WSS

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

With Wegovy coverage, Medicare patients may face high costs

This gene therapy has record $4.25 million price. It's saved children.

Diagnostic tests are hitting their mathematical limits

With Wegovy coverage, Medicare patients may face high costs

CDC director unscathed in first congressional testimony

entertainment

Wikipedia

focus

Wildfire smoke exposes gaps in outdoor worker protections

UnitedHealth’s Optum accused of antitrust violations in California

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

UnitedHealth’s Optum accused of antitrust violations in California

How to save PrEP access — and even expand it

Pregnancy ages women, but effects reverse after delivery

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

U.K. Biobank has 500,000 peoples' genome sequences available

Medicare proposal to cover medical devices draws a mixed reaction

Mirador, a new biotech startup, launches with $400 million

focus

With clinical trial data readouts, here's how to spot spin

With clinical trial data readouts, here's how to spot spin

UnitedHealth’s Optum accused of antitrust violations in California

6 surprising facts about sugar

Asbestos ban is immediate, but health effects will linger for decades

Chinese researcher claims birth of first gene

Wikipedia

leisure time

Wikipedia

hotspot